Compounds > 2-tert-butylhydroquinone
Page last updated: 2024-08-21

2-tert-butylhydroquinone and Parkinson Disease

2-tert-butylhydroquinone has been researched along with Parkinson Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Cai, X; Chen, L; Hong, F; Kuang, S; Li, Y; Ma, X; Qi, W; Shi, M; Wang, L; Xu, R; Xue, L; Ye, H; Zhang, R1
Ando, DM; Daub, A; Finkbeiner, S; Finucane, MM; Hwang, V; Lee, AK; Modan, S; Ravisankar, A; Shaby, BA; Skibinski, G1
Adachi, T; Hara, H; Kuno, S; Ohta, K; Ohta, M1
Jakel, RJ; Johnson, DA; Johnson, JA; Kern, JT1

Other Studies

4 other study(ies) available for 2-tert-butylhydroquinone and Parkinson Disease

ArticleYear
Identification and optimization of piperine analogues as neuroprotective agents for the treatment of Parkinson's disease via the activation of Nrf2/keap1 pathway.
    European journal of medicinal chemistry, 2020, Aug-01, Volume: 199

    Topics: Alkaloids; Animals; Apoptosis; Behavior, Animal; Benzodioxoles; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Kelch-Like ECH-Associated Protein 1; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; NF-E2-Related Factor 2; Parkinson Disease; PC12 Cells; Piperidines; Polyunsaturated Alkamides; Rats; Structure-Activity Relationship

2020
Nrf2 mitigates LRRK2- and α-synuclein-induced neurodegeneration by modulating proteostasis.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 01-31, Volume: 114, Issue:5

    Topics: alpha-Synuclein; Animals; Cerebral Cortex; Genes, Reporter; HEK293 Cells; Humans; Hydroquinones; Inclusion Bodies; Induced Pluripotent Stem Cells; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Nerve Tissue Proteins; Neurons; NF-E2-Related Factor 2; Parkinson Disease; Primary Cell Culture; Protein Aggregation, Pathological; Proteostasis; Rats; Recombinant Fusion Proteins; Single-Cell Analysis; Time Factors

2017
Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells.
    Brain research. Molecular brain research, 2003, Nov-26, Volume: 119, Issue:2

    Topics: Antioxidants; Cell Death; Cell Line, Tumor; Dose-Response Relationship, Drug; Glutathione; Humans; Hydroquinones; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Models, Neurological; NAD(P)H Dehydrogenase (Quinone); Neuroblastoma; Neurons; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Reactive Oxygen Species; RNA, Messenger; Transcriptional Activation

2003
Induction of the protective antioxidant response element pathway by 6-hydroxydopamine in vivo and in vitro.
    Toxicological sciences : an official journal of the Society of Toxicology, 2005, Volume: 87, Issue:1

    Topics: Animals; Antioxidants; Apoptosis; Astrocytes; Brain Stem; Corpus Striatum; DNA-Binding Proteins; Female; Hydroquinones; Mice; NF-E2-Related Factor 2; Oxidative Stress; Oxidopamine; Parkinson Disease; Receptors, N-Methyl-D-Aspartate; Response Elements; Trans-Activators

2005